Literature DB >> 22427511

NADPH oxidase-derived ROS and the regulation of pulmonary vessel tone.

G Frazziano1, H C Champion, P J Pagano.   

Abstract

Pulmonary vessel constriction results from an imbalance between vasodilator and vasoconstrictor factors released by the endothelium including nitric oxide, endothelin, prostanoids, and reactive oxygen species (ROS). ROS, generated by a variety of enzymatic sources (such as mitochondria and NADPH oxidases, a.k.a. Nox), appear to play a pivotal role in vascular homeostasis, whereas elevated levels effect vascular disease. The pulmonary circulation is very sensitive to changes in the partial pressure of oxygen and differs from the systemic circulation in its response to this change. In fact, the pulmonary vessels contract in response to low oxygen tension, whereas systemic vessels dilate. Growing evidence suggests that ROS production and ROS-related pathways may be key factors that underlie this differential response to oxygen tension. A major emphasis of our laboratory is the role of Nox isozymes in cardiovascular disease. In this review, we will focus our attention on the role of Nox-derived ROS in the control of pulmonary vascular tone.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22427511      PMCID: PMC3378288          DOI: 10.1152/ajpheart.00780.2011

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  194 in total

1.  Role for Nox1 NADPH oxidase in atherosclerosis.

Authors:  Andrea L Sheehan; Samuel Carrell; Bryon Johnson; Bojana Stanic; Botond Banfi; Francis J Miller
Journal:  Atherosclerosis       Date:  2011-02-24       Impact factor: 5.162

Review 2.  NADPH oxidase-derived reactive oxygen species: involvement in vascular physiology and pathology.

Authors:  Adrian Manea
Journal:  Cell Tissue Res       Date:  2010-11-05       Impact factor: 5.249

Review 3.  Soluble guanylate cyclase as an emerging therapeutic target in cardiopulmonary disease.

Authors:  Johannes-Peter Stasch; Pál Pacher; Oleg V Evgenov
Journal:  Circulation       Date:  2011-05-24       Impact factor: 29.690

4.  NADPH oxidase Nox1 contributes to ischemic injury in experimental stroke in mice.

Authors:  Timo Kahles; Andreas Kohnen; Sabine Heumueller; Angelika Rappert; Ingo Bechmann; Stefan Liebner; Ina M Wittko; Tobias Neumann-Haefelin; Helmuth Steinmetz; Katrin Schroeder; Ralf P Brandes
Journal:  Neurobiol Dis       Date:  2010-05-23       Impact factor: 5.996

5.  Neutral sphingomyelinase, NADPH oxidase and reactive oxygen species. Role in acute hypoxic pulmonary vasoconstriction.

Authors:  Giovanna Frazziano; Laura Moreno; Javier Moral-Sanz; Carmen Menendez; Lucía Escolano; Constancio Gonzalez; Eduardo Villamor; Jose Luis Alvarez-Sala; Angel L Cogolludo; Francisco Perez-Vizcaino
Journal:  J Cell Physiol       Date:  2011-10       Impact factor: 6.384

Review 6.  Redox signaling and reactive oxygen species in hypoxic pulmonary vasoconstriction.

Authors:  Beate Fuchs; Natascha Sommer; Alexander Dietrich; Ralph Theo Schermuly; Hossein Ardeschir Ghofrani; Friedrich Grimminger; Werner Seeger; Thomas Gudermann; Norbert Weissmann
Journal:  Respir Physiol Neurobiol       Date:  2010-08-27       Impact factor: 1.931

7.  Nox2-derived reactive oxygen species contribute to hypercholesterolemia-induced inhibition of neovascularization: effects on endothelial progenitor cells and mature endothelial cells.

Authors:  Paola Haddad; Sylvie Dussault; Jessika Groleau; Julie Turgeon; Fritz Maingrette; Alain Rivard
Journal:  Atherosclerosis       Date:  2011-04-05       Impact factor: 5.162

8.  Vascular smooth muscle cell NAD(P)H oxidase activity during the development of hypertension: Effect of angiotensin II and role of insulinlike growth factor-1 receptor transactivation.

Authors:  Montserrat C Cruzado; Norma R Risler; Roberto M Miatello; Guoying Yao; Ernesto L Schiffrin; Rhian M Touyz
Journal:  Am J Hypertens       Date:  2005-01       Impact factor: 2.689

9.  Role of endothelial Nox2 NADPH oxidase in angiotensin II-induced hypertension and vasomotor dysfunction.

Authors:  Colin E Murdoch; Sara P Alom-Ruiz; Minshu Wang; Min Zhang; Simon Walker; Bin Yu; Alison Brewer; Ajay M Shah
Journal:  Basic Res Cardiol       Date:  2011-04-29       Impact factor: 17.165

10.  The absence of reactive oxygen species production protects mice against bleomycin-induced pulmonary fibrosis.

Authors:  Boris Manoury; Soazig Nenan; Olivier Leclerc; Isabelle Guenon; Elisabeth Boichot; Jean-Michel Planquois; Claude P Bertrand; Vincent Lagente
Journal:  Respir Res       Date:  2005-01-21
View more
  38 in total

Review 1.  NADPH oxidase: its potential role in promotion of pulmonary arterial hypertension.

Authors:  Jing-Jie Peng; Bin Liu; Jin-Yun Xu; Jun Peng; Xiu-Ju Luo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-02-11       Impact factor: 3.000

2.  Metabolism and Redox in Pulmonary Vascular Physiology and Pathophysiology.

Authors:  Norah Alruwaili; Sharath Kandhi; Dong Sun; Michael S Wolin
Journal:  Antioxid Redox Signal       Date:  2018-12-21       Impact factor: 8.401

3.  Galectin-3: A Harbinger of Reactive Oxygen Species, Fibrosis, and Inflammation in Pulmonary Arterial Hypertension.

Authors:  David J R Fulton; Xueyi Li; Zsuzsanna Bordan; Yusi Wang; Keyvan Mahboubi; R Daniel Rudic; Stephen Haigh; Feng Chen; Scott A Barman
Journal:  Antioxid Redox Signal       Date:  2019-03-29       Impact factor: 8.401

4.  TrACEing angiotensin II type 1 to right ventricular hypertrophy: are the "sartans" a viable course to treating pulmonary arterial hypertension?

Authors:  Daniel Ranayhossaini; Patrick J Pagano
Journal:  Am J Respir Crit Care Med       Date:  2012-10-15       Impact factor: 21.405

Review 5.  Microvascular NADPH oxidase in health and disease.

Authors:  Yao Li; Patrick J Pagano
Journal:  Free Radic Biol Med       Date:  2017-03-06       Impact factor: 7.376

6.  Galectin-3 Promotes ROS, Inflammation, and Vascular Fibrosis in Pulmonary Arterial Hypertension.

Authors:  Scott A Barman; Zsuzsanna Bordan; Robert Batori; Stephen Haigh; David J R Fulton
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

7.  Overview on Interactive Role of Inflammation, Reactive Oxygen Species, and Calcium Signaling in Asthma, COPD, and Pulmonary Hypertension.

Authors:  Lillian Truong; Yun-Min Zheng; Sharath Kandhi; Yong-Xiao Wang
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

8.  Involvement of NADPH oxidase in A2A adenosine receptor-mediated increase in coronary flow in isolated mouse hearts.

Authors:  Zhichao Zhou; Uthra Rajamani; Hicham Labazi; Stephen L Tilley; Catherine Ledent; Bunyen Teng; S Jamal Mustafa
Journal:  Purinergic Signal       Date:  2015-04-25       Impact factor: 3.765

Review 9.  Autophagy of mitochondria: a promising therapeutic target for neurodegenerative disease.

Authors:  Pradip K Kamat; Anuradha Kalani; Philip Kyles; Suresh C Tyagi; Neetu Tyagi
Journal:  Cell Biochem Biophys       Date:  2014-11       Impact factor: 2.194

Review 10.  Impact of glucose-6-phosphate dehydrogenase deficiency on the pathophysiology of cardiovascular disease.

Authors:  Peter A Hecker; Jane A Leopold; Sachin A Gupte; Fabio A Recchia; William C Stanley
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-12-15       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.